MORRISVILLE, North Carolina, March 15, 2017 /PRNewswire/ --
Worldwide Clinical Trials has been recognized for excellence in clinical research by Life Science Leader's 2017 CRO Leadership Awards. Worldwide came away a winner in 12 of the 15 potential categories in the annual awards program, which is based on a survey of biopharmaceutical company executives who have decision-making influence and authority when it comes to working with clinical research organizations (CROs).
"We're thrilled to be honored in Life Science Leader's 2017 CRO Leadership Awards for the fourth year in a row. To be consistently recognized in this way by our customers who participate in the survey reflects the Worldwide team's integrity and commitment to quality," commented Peter Benton, President and Chief Operating Officer at Worldwide Clinical Trials. "Each and every day, we put our customers first and are dedicated to collaborating with them to help them achieve their goals."
The awards program recognizes companies for their performance across five core categories: capabilities, compatibility, expertise, quality and reliability. Winners are judged by their customers as either exceeding expectations or as top performers, and CROs have the opportunity to be recognized in up to three groups - "Big Pharma," "Small Pharma," and "Overall" (combined Big and Small Pharma). Here are Worldwide's 2017 winning categories:
"Life Science Leader is proud to be working with ISR Reports to honor those CROs that have proven themselves to be the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. The CROs receiving an award this year are truly at the top of their class, and are deserving of the recognition they receive. Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients," commented Ed Miseta, Executive Editor, Life Science Leader.
Connect with Worldwide Clinical Trials:
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.worldwide.com.
SOURCE Worldwide Clinical Trials
Advertisement
Worldwide Clinical Trials has been recognized for excellence in clinical research by Life Science Leader's 2017 CRO Leadership Awards. Worldwide came away a winner in 12 of the 15 potential categories in the annual awards program, which is based on a survey of biopharmaceutical company executives who have decision-making influence and authority when it comes to working with clinical research organizations (CROs).
Advertisement
"We're thrilled to be honored in Life Science Leader's 2017 CRO Leadership Awards for the fourth year in a row. To be consistently recognized in this way by our customers who participate in the survey reflects the Worldwide team's integrity and commitment to quality," commented Peter Benton, President and Chief Operating Officer at Worldwide Clinical Trials. "Each and every day, we put our customers first and are dedicated to collaborating with them to help them achieve their goals."
The awards program recognizes companies for their performance across five core categories: capabilities, compatibility, expertise, quality and reliability. Winners are judged by their customers as either exceeding expectations or as top performers, and CROs have the opportunity to be recognized in up to three groups - "Big Pharma," "Small Pharma," and "Overall" (combined Big and Small Pharma). Here are Worldwide's 2017 winning categories:
- Capabilities (Overall & Small Pharma)
- Compatibility (Overall & Small Pharma)
- Expertise (Overall, Big Pharma, Small Pharma)
- Quality (Overall & Small Pharma)
- Reliability (Overall, Big Pharma, Small Pharma)
"Life Science Leader is proud to be working with ISR Reports to honor those CROs that have proven themselves to be the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. The CROs receiving an award this year are truly at the top of their class, and are deserving of the recognition they receive. Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients," commented Ed Miseta, Executive Editor, Life Science Leader.
Connect with Worldwide Clinical Trials:
- Tweet: @worldwidetrials recognized in Life Science Leader's 2017 CRO Leadership Awards
- Follow us on Twitter: @worldwidetrials
- Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.worldwide.com.
SOURCE Worldwide Clinical Trials
